Abstract:The 5- and 10-year survival of lung transplantation in Japan is currently approximately 73% and 60%, respectively (1). Compared with the international registry data, which show 5- and 10-year survival of lung transplantation is approximately 55–60% and 35–40%, respectively (2), the outcome of lung transplantation in Japan is relatively good. However, the reason has not been well documented. In this special series entitled "Why is the Outcome Good? Secrets of Lung Transplantation in Japan" in the Journal of Thoracic Disease , we, the authors participating lung-transplant practice in active lung-transplant centers, have tried to explore the reasons why the outcome of lung transplantation has been relatively good. Through the 10 review articles and 1 original article from active lung transplant centers in Japan, we have figured out that this is (perhaps not surprisingly) multifactorial and the outcome is the net sum of each single component of lung transplantation that has been meticulously managed and refined. Namely, there was no real secret or magic bullet of lung transplantation in Japan. This special series would be a good lesson to learn for the medical and surgical professionals involved in lung transplantation worldwide, especially for those who are starting or have started a new lung-transplant program as a center or as a nation. On the other hand, there remains a question as to the sustainability of the lung-transplant system in Japan. The number of lung transplantation in Japan has been relatively small in general (in total approximately 1,000 cases in the last 20 years). However, now the number is increasing relatively rapidly (126 cases in 2023) and further incase is anticipated because of the increasing number of deceased organ donations. It is possible that the outcome was achievable only because of the limited number of patients, for whom Japanese transplant surgeons/physicians have taken overwhelming time and effort. It is indeed a serious issue for some relatively high-volume centers in Japan like ours (now conducting 40–50 cases/year) to maintain the quality of patient management with the limited personnel. Thus, each article of the special series will be a good indicator even for Japanese lung transplant physicians and surgeons as to the standard of care in 2024 in Japan and what could be changed in the pursuit of efficacy and what should be perpetuated in the future. Funding: None. Provenance and Peer Review: This article was commissioned by the editorial office, Journal of Thoracic Disease , for the series "Why is the Outcome Good? Secrets of Lung Transplantation in Japan". The article did not undergo external peer review. Conflicts of Interest: The author has completed the ICMJE uniform disclosure form (available at https://jtd.amegroups.com/article/view/10.21037/jtd-24-1070/coif). M.S. served as the unpaid Guest Editor of the series. The series "Why is the Outcome Good? Secrets of Lung Transplantation in Japan" was commissioned by the editorial office without any funding or sponsorship. The author has no other conflicts of interest to declare. Ethical Statement: The author is accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/. Masaaki Sato, MD, PhD Department of Thoracic Surgery, The University of Tokyo Hospital, Tokyo, Japan (Email: satom-sur@h.u-tokyo.ac.jp) Keywords: Lung transplantation; Japan; survival Submitted Jul 04, 2024. Accepted for publication Aug 16, 2024. Published online Aug 28, 2024. doi: 10.21037/jtd-24-1070

Prognostic factors for lung transplant recipients focusing on age and gender: the Japanese lung transplantation report 2022

Elderly lung transplant recipients show acceptable long-term outcomes for lung transplantation: A propensity score-matched analysis

Prognostic factors and outcomes in Japanese lung transplant candidates with interstitial lung disease

Donor and recipient age matching in lung transplantation: A retrospective study

Preface: why is the outcome good?—secrets of lung transplantation in Japan

A single-center analysis of lung transplantation outcomes in recipients aged 70 or older

COVID-19 pneumonia in lung transplant recipients: understanding risk factors and treatment outcomes in Japan

Patient selection, surgery and perioperative management in lung transplantation in Japan

A narrative review on the management of patients awaiting lung transplantation in Japan

The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-eighth adult lung transplantation report - 2021; Focus on recipient characteristics

Comparison of Prognosis for Lung Transplantation between Older and Younger Donors: A Systematic Review and Meta-Analysis Based on Cohort Studies

A Single-center Experience With >200 Lung Transplant Recipients With COVID-19 Infection

Increased Donor Organ Size and Age is Associated with Reduced Survival in Female Lung Transplant Recipients

Impact of Donor Age on Liver Transplant Outcomes in Patients with Acute-on-Chronic Liver Failure: A Cohort Study.

Improved survival of pediatric deceased donor liver transplantation recipients after introduction of the pediatric prioritization system: Analysis of data from a Japanese national survey

Donor and Recipient Age in Interstitial Lung Disease: Types of Lung Transplant Survival Outcomes

Impact of donor age ≥65 years on graft survival in large lung transplant cohorts

The history of Japanese lung transplantation: the unique pathway to establishing the program and its initial success

Risk factors for mortality in lung transplant recipients aged ≥65 years: A retrospective cohort study of 5,815 patients in the scientific registry of transplant recipients

OPTN/SRTR 2022 Annual Data Report: Lung

Risk factors for the long-term survival of patients after lung transplantation